Skip to content

Clinical trials

Observational Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Observational Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20041
20054
20061
20072
20084
20094
20101
20142
20181
20215
20221
20233
20245
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting12
Active, not recruiting4
Terminated3
Withdrawn3
Not yet recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
SWOG Cancer Research Network3
Dana-Farber Cancer Institute2
Fondazione Italiana Linfomi - ETS2
Mayo Clinic2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
UNC Lineberger Comprehensive Cancer Center2
Wake Forest University Health Sciences2
iOMEDICO AG2
Assistance Publique - Hôpitaux de Paris1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia42
Leukemia, Lymphocytic, Chronic, B-Cell27
Lymphoma, B-Cell, Marginal Zone24
Lymphoma, Mantle-Cell21
Lymphoma, Follicular20
Lymphoma19
Lymphoma, Non-Hodgkin19
Lymphoma, Large B-Cell, Diffuse18
Precursor Cell Lymphoblastic Leukemia-Lymphoma18
Multiple Myeloma17

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.